---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-027482"
form_type: "8-K"
ticker: "NVNO"
cik: "0001661053"
company_name: "enVVeno Medical Corp"
filed_at: "2025-12-12T23:59:59+00:00"
generated_at: "2026-05-16T13:21:47.195654+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# enVVeno stockholders reject 2025 equity plan; authorize reverse stock split

## Summary
- Elected Jenusaitis (3.47M for, 1.80M withheld) and Berman (4.73M for, 0.54M withheld) as Class II directors.
- Advisory say-on-pay passed: 3.19M for, 1.96M against, 5.79M broker non-votes.
- Stockholders voted AGAINST the 2025 Equity Incentive Plan (2.48M for, 2.62M against); 2016 plan remains.
- Approved reverse stock split authorization (7.31M for, 1.58M against) at ratio of 1:5 to 1:35 at Board discretion.
- Ratified CBIZ CPAs P.C. as auditor for FY2025 (10.86M for, 0.14M against).

## SEC filing metadata
- accession: 0001493152-25-027482
- form_type: 8-K
- ticker: NVNO
- cik: 0001661053
- company_name: enVVeno Medical Corp
- filed_at: 2025-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661053/000149315225027482/0001493152-25-027482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661053/000149315225027482/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-027482
- JSON: https://secwatch.observer/filing/0001493152-25-027482.json
- Plain text: https://secwatch.observer/filing/0001493152-25-027482.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.